Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 16Breast 5Genitourinary 4Gastrointestinal 4Head & Neck 1CNS 1

Conditions

Brain Neoplasms 3Neuroblastoma 1Neoplasms 1Lung Neoplasms 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Genetic Predisposition to Disease 1Central Nervous System Neoplasms 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 18Radiosurgery 15Radiotherapy 13Specimen Handling 11Pemetrexed 8Paclitaxel 6Erlotinib Hydrochloride 6Docetaxel 6Carboplatin 6Bevacizumab 5Temozolomide 4Spinal Puncture 4Cisplatin 4pembrolizumab 3osimertinib 3Taxes 3Nivolumab 3Gemcitabine 3Gefitinib 3Filgrastim 3Drug Therapy 3trametinib 2selpercatinib 2sapanisertib 2motexafin gadolinium 2epothilone B 2dabrafenib 2X-Rays 2Vorinostat 2Trastuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Interviews as Topic × CNS × Clear all
NCT06315296 2026-03-03

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

Thomas Jefferson University

Phase NA Terminated
1 enrolled
BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡